The Risk Factor Analysis for Recurrence in the Treatment of Choledochojejunostomy for Hepatolithiasis
-
摘要:
目的 探讨肝胆管结石患者采用胆管空肠术治疗后结石复发的危险因素。 方法 回顾性分析昆明医科大学第二附属医院2014年6月至2019年6月行胆管空肠吻合手术的肝胆管结石患者的临床资料。按照胆管结石复发标准将纳入患者分为复发组和非复发组,通过单因素和多因素分析确定肝胆管结石复发的相关危险因素。 结果 最终共纳入77例行胆管空肠吻合术的肝胆管结石患者,所有患者均随访成功,其中复发组21例,未复发组56例。单因素分析及多因素分析均显示:结石大小≥10 mm、胆总管直径 < 20 mm、多处结石、胆道炎症、吻合器吻合、无支撑管、无胆道引流、未行肝切除是胆管空肠吻合术后肝胆管结石复发的危险因素(P < 0.05)。 结论 结石≥10 mm、胆总管直径 < 20 mm、多处结石、胆道炎症、吻合器吻合、无支撑管、无胆道引流、未行肝切除是胆管空肠吻合术后肝胆管结石复发的危险因素。 Abstract:Objective To study the related risk factor of recurrence after the treatment of choledochojejunostomy in hepatolithiasis. Methods Retrospective analysis was performed on the clinical data of patients with hepatolithiasis who underwent biliary jejunostomy in the Second Affiliated Hospital of Kunming Medical University from June 2014 to June 2019.According to the criteria for recurrence of bile duct stones, the included patients were divided into the recurrence group and the non-recurrence group. Results A total of 77 patients with hepatolithiasis and undergoing the underwent choledochojejunostomy were included in this study, all of whom were followed up successfully, including 21 in the recurrence group and 56 in the non-recurrence group.Univariate analysis and multivariate analysis showed that stone size ≥10 mm, choledochal diameter < 20 mm, stone location, biliary inflammation, anastomotic anastomosis, no supporting tube, no biliary drainage and no hepatectomy were the risk factors for recurrence of hepatolithiasis after the biliary jejunectomy (P < 0.05). Conclusion Stone size ≥10 mm, choledochal diameter < 20 mm, stone location, biliary inflammation, anastomotic anastomosis, no supporting tube, no biliary drainage and no hepatectomy are the risk factors for the recurrence of hepatolithiasis after the biliary jejunectomy. -
Key words:
- Choledochojejunostomy /
- Hepatolithiasis /
- Recurrence /
- Risk factor
-
图 1 感染、炎症与结石形成的关系
1:细菌感染影响胆汁的产生和运输,寄生虫的蠕虫或卵可能导致梗阻,导致胆汁淤积;2:胆汁淤积加重感染;3:细菌、蠕虫及其分泌物易引起胆管损伤和炎症;4:正常胆管失去保护作用后易发生细菌性胆管炎;5、9:胆管损伤、炎症或狭窄时,胆管内的压力发生变化,导致胆汁淤积;6:有毒胆汁酸积聚导致胆管壁损伤和炎症;7:细菌产生相关物质,引起胆汁成分变化,最终沉积;8:胆管壁纤维化;10:胆汁淤积为胆汁成分沉积并形成结石提供了时间和地点;11:胆汁在狭窄的上方和下方产生回流和漩涡,为小颗粒的聚集提供额外的动力。
Figure 1. Relationship between infection,inflammation and stone formation
表 1 观察指标及取值
Table 1. Observation indexes and values
资料类型 项目 取值 一般临床
资料年龄 - 性别 男、女 BMI - 嗜酒史 有、无 吸烟史 有、无 高血压病史 有、无 糖尿病病史 有、无 肝炎病史 有、无 肝硬化病史 有、无 结石大小 < 10 mm和≥10 mm
(以影像学测量的最大
长径为观察值)胆总管直径 < 20 mm、≥20 mm
(以术前超声、MRI、
MRCP等影像学测量胆总管最大直径
为观察值)结石位置 单发、多发 术前合并胆道炎症 合并、不合并 手术相关
临床资料吻合术式 端侧、端端、侧侧 缝合方式 吻合器、手工 缝合方式 连续、间断 缝线粗细 3-0至4-0、5-0至6-0 胆道支撑管 有、无 胆道引流方式 有、无 肝切除 合并、不合并 术后胆漏 有、无 表 2 胆管空肠吻合术后肝胆管结石复发的单因素分析
Table 2. Single-factor analysis for recurrence in the treatment of choledochojejunostomy for hepatolithiasis
因素 复发组(n = 21) 未复发组(n = 56) t/χ2 P 年龄($\bar x \pm s $),岁 54.6 ± 7.9 58.7 ± 11.5 −1.499a 0.138 性别(男/女) 11/10 26/30 0.217 0.642 体重指数($\bar x \pm s $),kg/m2 22.5 ± 1.6 22.9 ± 1.4 0.568 a 0.537 吸烟史(有/无) 5/16 16/40 0.175 0.676 嗜酒史(有/无) 5/16 18/38 0.506 0.477 高血压病史(有/无) 1/20 6/50 0.655 0.418 糖尿病病史(有/无) 0/21 1/55 0.380 0.538 肝炎病史(有/无) 1/20 7/49 0.982 0.322 肝硬化病史(有/无) 1/20 2/54 0.058 0.810 结石大小( < 10 mm/≥10 mm) 2/19 26/30 8.989 0.003* 胆总管直径( < 20 mm/≥20 mm) 16/5 26/30 5.456 0.019* 结石位置(单处/多处) 3/18 21/35 4.353 0.037* 胆道炎症(是/否) 15/6 23/33 5.631 0.018* 吻合方式(吻合器/手工) 8/13 7/49 6.379 0.012* 缝合方式(连续/间断) 10/3 31/14 0.314 0.575 缝线粗细(3-0~4-0/5-0~6-0) 7/6 27/26 0.035 0.851 Y襻长度(40~60 cm/60~70 cm) 18/3 53/3 1.695 0.193 支撑管(有/无) 7/14 38/18 7.495 0.006* 胆道引流(有/无) 8/13 40/16 7.228 0.007* 合并肝切除(有/无) 6/15 35/21 5.631 0.018* 术后胆漏(合并/不合并) 3/18 1/55 4.845 0.028* *P < 0.05。 表 3 胆管空肠吻合术后肝胆管结石复发的多因素分析
Table 3. Multi-factor analysis for recurrence in the treatment of choledochojejunostomy for hepatolithiasis
因素 β OR SE P OR95%CI 结石大小( < 10 mm/≥10 mm) 1.783 2.359 0.332 0.028* 1.492,5.347 胆总管直径( < 20 mm/≥20 mm) 2.469 3.043 0.498 0.011* 1.335,4.269 结石位置(单处/多处) 1.943 2.314 0.671 0.020* 1.435,4.546 胆道炎症(是/否) 1.068 1.325 0.214 0.039* 1.134,3.291 吻合方式(吻合器/手工) 2.285 6.731 0.447 0.023* 1.362,12.257 支撑管(有/无) 3.125 4.583 0.584 0.016* 1.247,4.193 胆道引流(有/无) 4.421 7.586 0.815 0.007* 3.342,16.465 合并肝切除(有/无) 7.832 8.295 0.765 0.002* 5.386,17.537 术后胆漏(合并/不合并) 1.575 0.863 0.345 0.188 1.328,3.763 *P < 0.05。 -
[1] Cheon Y K,Cho Y D,Moon J H,et a1. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis[J]. Surgery,2009,146(5):843-853. doi: 10.1016/j.surg.2009.04.009 [2] 汤恢焕,周军,肖广发,等. 外科治疗2465例原发性肝内胆管结石的临床总结[J]. 中华外科杂志,2006,44(23):1610-1613. doi: 10.3760/j:issn:0529-5815.2006.23.009 [3] 国家卫生健康委员会公益性行业科研专项专家委员会. 肝胆管结石病胆肠吻合术应用专家共识(2019版)[J]. 中华消化外科杂志,2019,18(5):414-418. doi: 10.3760/cma.j.issn.1673-9752.2019.05.002 [4] 边大鹏,史继荣,田孝东,等. 胆管空肠吻合联合空肠盲袢固定标记在复发肝胆管结石治疗中应用研究[J]. 中国实用外科杂志,2020,40(6):715-718. [5] D Yao,Wu S. Application of laparoscopic technique in the treatment of hepatolithiasis[J]. Surg Laparosc Endosc Percutan Tech,2020,31(2):247-253. [6] 陈志宇,别平. 胆肠吻合在肝胆管结石治疗中的合理应用[J]. 中国实用外科杂志,2016,36(3):280-283. [7] 周杰,张起帆,孙世波,等. 肝胆管结石术中胆管引流方式合理选择[J]. 中国实用外科杂志,2016,36(3):286-289. [8] Dilek O N,Atasever A,Acar N,et al. Hepatolithiasis; case series, review and current management strategy[J]. Turk J Surg,2010,36(4):382-392. [9] Miyazaki T,Shinkawa H,Takemura S,et al. Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis[J]. Asian Pac J Cancer Prev,2020,21(12):3647-3654. [10] 梁力建. 肝胆管结石病治疗中的难点、误区与对策[J]. 中国实用外科杂志,2016,36(3):257-260,263. [11] 张多强,李坡,柳佰富,等. 消化道吻合器在胆肠吻合术中的应用[J]. 中国普通外科杂志,2011,20(4):432-433. [12] 赵晓春,张劭,李汉贤,等. 弯管型腔内吻合器胆肠吻合应用118例[J]. 中华肝胆外科杂志,2010,16(3):188-190. [13] 中华医学会外科学分会. 胆道手术缝合技术与缝合材料选择中国专家共识(2018版)[J]. 中国实用外科杂志,2019,39(1):15-20. [14] 李泽民,王启伦. 不同缝合方式对胆肠吻合术后并发症的影响[J]. 河北医学,2016,22(7):1103-1106. doi: 10.3969/j.issn.1006-6233.2016.07.018 [15] 周晋航,吴黎明,王江华,等. 不同缝合方式对胆肠吻合术后并发症的影响[J]. 临床肝胆病杂志,2015,31(10):1656-1659. doi: 10.3969/j.issn.1001-5256.2015.10.024 [16] 刘磊,刘付宝,赵义军,等. 胆肠内引流联合T管外引流术治疗肝胆管结石病疗效研究[J]. 中国实用外科杂志,2019,39(6):606-609. [17] 中华医学会外科学分会胆道外科学组. 肝胆管结石病诊断治疗指南[J]. 中华消化外科杂志,2007,6(2):156-161. doi: 10.3760/cma.j.issn.1673-9752.2007.02.028 [18] Nuzzo G,Clemente G,Giovannini I,et al. Liver resection for primary intrahepatic stones:A single-center experience[J]. Arch Surg,2008,143(6):570-573. doi: 10.1001/archsurg.143.6.570 [19] Tabrizian P,Jibara G,Shrager B,et al. Hepatic resection for primary hepatolithiasis:A single-center Western experience[J]. J Am Coll Surg,2012,215(5):622-626. doi: 10.1016/j.jamcollsurg.2012.07.005 [20] Uenishi T,Hamba H,Takemura S,et al. Outcomes of hepatic resection for hepatolithiasis[J]. Am J Surg,2009,198(2):199-202. doi: 10.1016/j.amjsurg.2008.08.020 [21] Li S Q,Liang L J,Peng B G,et al. Outcomes of liver resection for intrahepatic stones:A comparative study of unilateral versus bilateral disease[J]. Ann Surg,2012,255(5):946-953. doi: 10.1097/SLA.0b013e31824dedc2 [22] Yang T,Lau W Y,Lai E C,Y et al. Hepatectomy for bilateral primary hepatolithiasis:A cohort study[J]. Ann Surg,2010,251(1):84-90. doi: 10.1097/SLA.0b013e3181b2f374 [23] Fang C H,Liu J,Fan Y F,et al. Outcomes of hepatectomy for hepatolithiasis based on 3-dimensional reconstruction technique[J]. J Am Coll Surg,2013,217(2):280-288. doi: 10.1016/j.jamcollsurg.2013.03.017 [24] Jarufe N,Figueroa E,Munoz C,et al. Anatomic hepatectomy as a definitive treatment for hepatolithiasis:A cohort study[J]. HPB(Oxford),2012,14(9):604-610. [25] Jiang H,Jiang O,Xia X,et al. Laparoscopic versus open hepatectomy approach for regional hepatolithiasis: A meta-analysis[J]. J Chin Med Assoc,2018,81(5):429-436. [26] Koch M,Garden O J,Padbury R,et al. Bile leakage after hepatobiliary and pancreatic surgery:A definition and grading of severity by the International Study Group of Liver Surgery[J]. Surgery,2011,149(5):680-688. doi: 10.1016/j.surg.2010.12.002